Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 11Gastrointestinal 10Thoracic 4Sarcoma 2Lymphoid 2Gynecologic 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Sarcoma 2Venous Thromboembolism 1Thromboembolism 1Hematoma 1Bone Neoplasms 1

Interventions

Radiotherapy 215Cyclophosphamide 210Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Irinotecan 79Magnetic Resonance Spectroscopy 78pembrolizumab 75Radiation 66Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 44Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Enoxaparin × Sarcoma × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT01696760 2018-12-05

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology

Ohio State University Comprehensive Cancer Center

Phase NA Completed
12 enrolled 6 charts
Sarcoma

Sarcoma, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡